Crossmark

Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study

Crossref DOI link: https://doi.org/10.1186/s13613-025-01433-3

Published Print: 2025

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Krenn, Katharina

Kraft, Felix https://orcid.org/0000-0002-6297-9256
Mandroiu, Luana

Tretter, Verena

Reindl-Schwaighofer, Roman

Clement, Theresa

Domenig, Oliver

Vossen, Matthias G.

Riemann, Gregor

Poglitsch, Marko

Ullrich, Roman
Funding

Funding for this research was provided by:

Medical-scientific fund of the mayor of the capital Vienna (COVID 039)

Dept. of Anesthesia and General Intensive Care, Medical University of Vienna

Apeptico GmbH
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-11-17
More Information

This article is maintained by: Elsevier

Article Title: Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-025-01433-3

Content Type: article

Copyright: Copyright © 2025 The Author(s) 2025. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below